Curiteva

Executive Summary

Curiteva is a US-based medical device company pioneering 3D-printed PEEK technology for spinal implants. Its flagship Inspire® Trabecular PEEK platform creates fully porous, bioactive implants designed to enhance bone integration and improve surgical outcomes. The company has achieved regulatory approval and commercialized its technology for cervical, thoracolumbar, and sacroiliac applications. Curiteva is privately held and headquartered in Birmingham, Alabama. With a focus on innovation in orthopedics, the company addresses a significant market need for advanced spinal fusion solutions. Its 3D-printed PEEK implants offer potential advantages over traditional metal or PEEK-only implants, including improved osseointegration and reduced stress shielding. The company continues to expand its product portfolio and pursue clinical evidence to support adoption.

Upcoming Catalysts (preview)

• Q3 2026FDA Clearance for Novel Sacroiliac Fusion Implant60% success
• Q4 2026Strategic Partnership with Major Orthopedic Distributor60% success
• Q2 2026Publication of Clinical Outcomes for Inspire Trabecular PEEK in Cervical Fusion75% success